FDA Removes Top Expert on Vaping and Tobacco
More Than 3.8 Million U.S. Lung Cancer Deaths Averted During 1970 to 2022
Number of averted lung cancer deaths accounted for 51.4 percent of the estimated declines in overall cancer deaths
Major Job Cuts at NIOSH Pose Risks to Worker Safety, Critics Warn
Lung Cancer Screening Rates Increased After 2021 Update to USPSTF Guidelines
Lower odds of screening seen in association with lack of health insurance, being rural resident, not having a clinician
Adverse Outcomes Increased With Long-Term Inhaled Corticosteroids in COPD
Significantly greater composite adverse outcome rates seen for long- versus short-term inhaled corticosteroid use for prevalent, inception cohorts
NIH Ends Funding for the Effects of Climate Change on Health
Tuberculosis on the Rise Again in the United States
Preliminary data show 2024 rates were highest seen in more than 12 years
Molecular Residual Disease Analysis May Predict Disease Recurrence After Lung Cancer Resection
Molecular residual disease precedes DFS events in patients receiving osimertinib, placebo; most events occur after osimertinib discontinuation or completion
Denoised Ultra-Low-Dose CT Better for Identifying Lungs With, Without Pneumonia
Fine details better visualized in denoised ultra-low-dose CT images in adults who were immunocompromised
COPD Tied to Increased Risk for Death in Patients With Arthritis
Findings seen for both all-cause and cardiovascular disease mortality
